thalidomide has been researched along with phenylephrine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Cachofeiro, V; Davel, AP; De Sá, LL; Fukuda, LE; Lahera, V; Munhoz, CD; Rossoni, LV; Sanz-Rosa, D; Scavone, C | 1 |
Bexis, S; Docherty, JR; McCormick, PA; Seto, SW | 1 |
3 other study(ies) available for thalidomide and phenylephrine
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Effects of isoproterenol treatment for 7 days on inflammatory mediators in the rat aorta.
Topics: Acetylcholine; Adrenergic beta-Agonists; Animals; Aorta; Blotting, Western; Dose-Response Relationship, Drug; Electrophoretic Mobility Shift Assay; Hemodynamics; I-kappa B Proteins; Inflammation Mediators; Injections, Subcutaneous; Interleukin-1beta; Interleukin-6; Isoproterenol; Male; NF-KappaB Inhibitor alpha; Oxidative Stress; Phenylephrine; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sodium Salicylate; Superoxide Dismutase; Thalidomide; Transcription Factor RelA; Tumor Necrosis Factor-alpha; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 2008 |
Actions of thalidomide in producing vascular relaxations.
Topics: Angiogenesis Inhibitors; Animals; Aorta; Benzimidazoles; Blood Pressure; Calcium Channel Blockers; Calcium Channels, T-Type; Cyclopropanes; Dose-Response Relationship, Drug; Male; Naphthalenes; Phenylephrine; Rats; Rats, Wistar; Thalidomide; Vasoconstrictor Agents; Vasodilation | 2010 |